Year 2018 ACC Guideline Update: The ECDP Report on Non-Statin Therapies for ASHD Reduction in Diabetic Patients—Addressing Statin Intolerance, Poor Target LDL Goal Attainment and Resistance Syndromes in Diabetes Specialty Practice
Registration
Year 2018 ACC Guideline Update: The ECDP Report on Non-Statin Therapies for ASHD Reduction in Diabetic Patients—Addressing Statin Intolerance, Poor Target LDL Goal Attainment and Resistance Syndromes in Diabetes Specialty Practice
Would you like to continue where you left off?
Year 2018 ACC Guideline Update: The ECDP Report on Non-Statin Therapies for ASHD Reduction in Diabetic Patients—Addressing Statin Intolerance, Poor Target LDL Goal Attainment and Resistance Syndromes in Diabetes Specialty Practice
